| Phosphorylated RB promotes cancer immunity by inhibiting NF-κB activation and PD-L1 expression X Jin, D Ding, Y Yan, H Li, B Wang, L Ma, Z Ye, T Ma, Q Wu, ... Molecular cell 73 (1), 22-35. e6, 2019 | 205 | 2019 |
| Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells X Qu, P Wang, D Ding, L Li, H Wang, L Ma, X Zhou, S Liu, S Lin, X Wang, ... Nucleic acids research 41 (16), 7771-7782, 2013 | 186 | 2013 |
| DUB3 promotes BET inhibitor resistance and cancer progression by deubiquitinating BRD4 X Jin, Y Yan, D Wang, D Ding, T Ma, Z Ye, R Jimenez, L Wang, H Wu, ... Molecular cell 71 (4), 592-605. e4, 2018 | 135 | 2018 |
| Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B DK Jiang, XP Ma, H Yu, G Cao, DL Ding, H Chen, HX Huang, YZ Gao, ... Hepatology 62 (1), 118-128, 2015 | 81 | 2015 |
| Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability W Jiang, H Huang, L Ding, P Zhu, H Saiyin, G Ji, J Zuo, D Han, Y Pan, ... Oncogene 34 (34), 4460-4470, 2015 | 74 | 2015 |
| Destruction of DNA‐binding proteins by programmable oligonucleotide PROTAC (O'PROTAC): effective targeting of LEF1 and ERG J Shao, Y Yan, D Ding, D Wang, Y He, Y Pan, W Yan, A Kharbanda, H Li, ... Advanced Science 8 (20), 2102555, 2021 | 73 | 2021 |
| CCL3L1 copy number variation and susceptibility to HIV-1 infection: a meta-analysis SJ Liu, L Yao, DL Ding, HZ Zhu PloS one 5 (12), e15778, 2010 | 61 | 2010 |
| Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation D Ding, X Qu, L Li, X Zhou, S Liu, S Lin, P Wang, S Liu, C Kong, X Wang, ... Virology 440 (2), 182-189, 2013 | 60 | 2013 |
| Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis DK Jiang, XP Ma, X Wu, L Peng, J Yin, Y Dan, HX Huang, DL Ding, ... Scientific reports 5 (1), 16278, 2015 | 54 | 2015 |
| HDAC5 loss impairs RB repression of pro-oncogenic genes and confers CDK4/6 inhibitor resistance in cancer Y Zhou, X Jin, J Ma, D Ding, Z Huang, H Sheng, Y Yan, Y Pan, T Wei, ... Cancer research 81 (6), 1486-1499, 2021 | 47 | 2021 |
| Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway D Ding, H Huang, W Jiang, W Yu, H Zhu, J Liu, H Saiyin, J Wu, S Jiang, ... Oncogene 36 (48), 6691-6700, 2017 | 42 | 2017 |
| DNA damage promotes TMPRSS2-ERG oncoprotein destruction and prostate cancer suppression via signaling converged by GSK3β and WEE1 Z Hong, W Zhang, D Ding, Z Huang, Y Yan, W Cao, Y Pan, X Hou, ... Molecular Cell 79 (6), 1008-1023. e4, 2020 | 34 | 2020 |
| Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma W Wang, XP Ma, Z Shi, P Zhang, DL Ding, HX Huang, HG Saiyin, ... American Journal of Cancer Research 5 (1), 396, 2015 | 34 | 2015 |
| ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication D Wang, J Ma, MV Botuyan, G Cui, Y Yan, D Ding, Y Zhou, EW Krueger, ... Science Advances 7 (25), eabd9208, 2021 | 32 | 2021 |
| Zinc finger nuclease: a new approach for excising HIV-1 proviral DNA from infected human T cells X Qu, P Wang, D Ding, X Wang, G Zhang, X Zhou, L Liu, X Zhu, H Zeng, ... Molecular biology reports 41, 5819-5827, 2014 | 22 | 2014 |
| Association between the CCR2-Val64Ile polymorphism and susceptibility to HIV-1 infection: a meta-analysis DL Ding, SJ Liu, HZ Zhu Molecular Medicine Reports 4 (1), 181-186, 2011 | 15 | 2011 |
| CYCLIN K down-regulation induces androgen receptor gene intronic polyadenylation, variant expression and PARP inhibitor vulnerability in castration-resistant prostate cancer R Sun, T Wei, D Ding, J Zhang, S Chen, HH He, L Wang, H Huang Proceedings of the National Academy of Sciences 119 (39), e2205509119, 2022 | 13 | 2022 |
| 3-Aminophthalic acid, a new cereblon ligand for targeted protein degradation by O’PROTAC Y Yan, J Shao, D Ding, Y Pan, P Tran, W Yan, Z Wang, H Li, H Huang Chemical Communications 58 (14), 2383-2386, 2022 | 13 | 2022 |
| miR-492G> C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients G Yu, Q Xiao, XP Ma, X Chen, Z Shi, LY Zhang, H Chen, P Zhang, ... Tumor Biology 37, 8961-8972, 2016 | 12 | 2016 |
| MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma XP Ma, G Yu, X Chen, Q Xiao, Z Shi, LY Zhang, H Chen, P Zhang, ... Tumor Biology 37, 9931-9942, 2016 | 12 | 2016 |
